Conceive, Evernow, FitOn, Nurx, Cove, and Nutrium Join as Founding Members to Support the Coalition’s Focus on Expanding Access to...
The healthcare technology leader was recognized in 28 G2 Spring 2024 Reports and earned 9 badges in G2's spring report,...
I Am Boundless Inc. Focuses on Integration and Patient Outcomes Across 50+ Counties in the StateREMOTE-FIRST COMPANY/WORTHINGTON, Ohio--(BUSINESS WIRE)--#NextGenHealthcare--Driven by...
Smile offers enhanced interoperability with their new solution that converts clinical documents to the widely used FHIR standard.TORONTO, ON /...
NORTHAMPTON, MA / ACCESSWIRE / May 28, 2024 / Originally published on Bristol Myers Squibb News & PerspectivesGlobally, communities are...
TALLAHASSEE, FL / ACCESSWIRE / May 28, 2024 / Ascend Plastic Surgery Partners (Ascend), a leading network of top-tier plastic...
NORTHAMPTON, MA / ACCESSWIRE / May 28, 2024 / Gilead Sciences:In an effort to advance access to cancer prevention and...
STONY BROOK, NY / ACCESSWIRE / May 28, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"),...
VANCOUVER, WA / ACCESSWIRE / May 28, 2024 / Sinceri Senior Living, a distinguished senior living management company, is thrilled...
Strategic focus on India aims to make the Swoop® portable MR brain imaging system commercially available in a vast and...
SAN FRANCISCO, CA / ACCESSWIRE / May 28, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") family company Napo Pharmaceuticals ("Napo")...
NORTHAMPTON, MA / ACCESSWIRE / May 28, 2024 / CARE CARE has supported 16.5 million women and girls to increase...
TORONTO, ON / ACCESSWIRE / May 28, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), a biopharmaceutical company dedicated to...
NEW YORK, NY / ACCESSWIRE / May 28, 2024 / Five Southern states rank as the worst in the nation...
ZÜRICH, SWITZERLAND / ACCESSWIRE / May 28, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage...
Phase 2 study to assess updated formulations for improved immune responses of multivalent vaccine candidate against influenza B strainStudy initiated...
Partnership expands spectrum of Secarna's capabilities for the development of targeted ASOs beyond antibodies and sugar moleculesNew platform capabilities extend...
Data demonstrate lowest reported primary endpoint event rate of 1.95% through twelve months post-procedure for any carotid stent or embolic...
ATRN-119 is the first and only macrocyclic ATR inhibitor in the clinic, with best in class potential On track to...
TORONTO, May 28, 2024 (GLOBE NEWSWIRE) -- Workhorse Health is on a mission to bridge the gap in mental health...